KRAS and adenoma: Adenomas with RASSF2 methylation were more likely to carry K-ras/BRAF mutations than those without RASSF2 methylation (73 vs 30%, P<0.01), suggesting that these genetic and epigenetic alterations are mutually correlated and may work synergistically.